Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
Borisov Se, Valentina Marchese(German Center for Infection Research), R. Gomez Rosso(Universidad Nacional de Asunción), Līga Kukša(Riga East University Hospital), Raquel Duarte(Universidade do Porto), Vygantas Gruslys(Vilnius University), Edvardas Danila(Istituti Clinici Scientifici Maugeri), Maurizio Ferrarese(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Alena Skrahina(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Seifeldin Eltaeb Elamin(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Justin T. Denholm, Filippov Av, Margareth Pretti Dalcolmo(Fundação Instituto de Pesca do Estado do Rio de Janeiro), Onno W. Akkerman(University Medical Center Groningen), Jerker Jonsson(Public Health Agency of Sweden), Judith Bruchfeld(National Health Service), Jorge De Los Ríos, Wouter Hoefsloot(Radboud University Nijmegen), Enrique Bernal(Honeywell (United States)), Vinicio Manfrin(Ospedale San Bortolo), Gina Gualano(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Edita Davidavičienė(Vilnius University Hospital Santariskiu Klinikos), Blagovesta Gavazova, Rafael Laniado-Laborı́n(Universidad Autónoma de Baja California), Elena Khimova(Northern State Medical University), Evgeny Belilovski(Government of Russia), Masoud Dara(World Health Organization Regional Office for Europe), Saulius Diktanas, Antoniya Koleva(Technical University of Gabrovo), Luigi Ruffo Codecasa(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Selene Manga(National University of Saint Anthony the Abbot in Cuzco), Heinke Kunst(Queen Mary University of London), Martin J. Boeree(Radboud University Nijmegen), Regina Gayoso(Karolinska University Hospital), Lina Davies Forsman(Karolinska University Hospital), Jacinta Drakšienė(Republic Klaipeda Hospital), Alena Aleksa(Grodno State Medical University), Skaidrius Miliauskas(Lithuanian University of Health Sciences), Yang Li(Fudan University), José-María García-García(The University of Sydney), Cécile Magis-Escurra(Radboud University Nijmegen), Qingshan Cai(Integrated Chinese Medicine (China)), Nadia Escobar Salinas(Ministry of Health), Ana Maria Garcı́a(Hospital Muñiz), Zarir Udwadia(P. D. Hinduja Hospital and Medical Research Centre), Andrei Maryandyshev(Northern State Medical University), Alberto Piubello(Damien Foundation), José Joaquín Cebrián Gallardo, Ieva Gaudiešiūtė(Lithuanian University of Health Sciences)
Cited by 176
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
|The Lancet Respiratory Medicine|2014|648
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
|The Lancet|2018|639
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by <i>Mycobacterium avium</i> Complex (CONVERT). A Prospective, Open-Label, Randomized Study
|American Journal of Respiratory and Critical Care Medicine|2018|343